Unknown NA INTERVENTIONAL 2-arm NCT01277627

Influence of Nevirapine on HCV Viral Load (HELICON)

Influence of Nevirapine on HCV Viral Load Among HIV/HCV-coinfected Patients

Sponsor: Boehringer Ingelheim

Conditions HCV Infection. HCV Viral Load.

Interventions Nevirapine efavirenz, protease inhibitors

Updated 4 times since 2017 Last updated: Jan 14, 2011 Started: Jan 31, 2011 Primary completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01277627, this NA trial focuses on HCV Infection. and HCV Viral Load. and remains ongoing. Sponsored by Boehringer Ingelheim, it has been updated 4 times since 2011, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jan 2017 — Jan 2021 [monthly]

Unknown Status NA

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boehringer Ingelheim
Valme University Hospital

Data source: Valme University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seville, Spain